Respiratory Cyanide Antidote Composition for Fireground Smoke
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies fail to provide comprehensive protection against both solid and gaseous hazardous substances in fireground smoke, leading to health risks for firefighters and inspectors, as they cannot effectively neutralize hydrogen cyanide, particulate matters, and free radicals, and existing antidotes have limitations in dosage forms and applicability.
Innovation Solution
A composition for upper respiratory tract administration comprising a cyanide antidote, a metal chelator, and an expectorant, which can be administered via nebulization to neutralize toxic gases, block free radical chain reactions, and promote mucous excretion, providing rapid protection and treatment against cyanide poisoning and smoke-related injuries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If intravenous injection of hydroxocobalamin is used, then cyanide antidote effect is achieved, but applicability in fireground environment is limited
Solution Approach 1:
The patent replaces the mechanical injection system (intravenous injection) with a respiratory administration system (inhalation/nebulization). This substitution allows the cyanide antidote to be delivered through the respiratory tract, making it applicable in fireground environments where injection equipment and trained personnel may not be immediately available, while still achieving effective cyanide neutralization.
2Object-affected harmful factors
If antigas cartridge is used, then toxic gases are filtered, but filtering time is too long
Solution Approach 1:
The patent administers the cyanide antidote (hydroxocobalamin) in advance through inhalation before cyanide exposure occurs or while exposure is happening. This preliminary action creates protective cyanocobalamin in the body beforehand, eliminating the need for time-consuming filtration processes and providing immediate protection against cyanide toxicity.
Solution Approach 2:
The patent converts the harmful cyanide gas into beneficial cyanocobalamin (vitamin B12) by having the inhaled hydroxocobalamin react with cyanide in the body. This transformation turns the toxic substance into a beneficial vitamin, providing both protection and treatment simultaneously without requiring filtration time.
3Object-affected harmful factors
If physical protective equipment is worn, then respiratory protection is provided, but particulate matters cannot be completely filtered
Solution Approach 1:
The patent introduces hydroxocobalamin as a chemical intermediary that directly neutralizes cyanide toxins in the body. Unlike physical barriers that attempt to filter particulates, this intermediary substance chemically binds with cyanide to form non-toxic cyanocobalamin, providing reliable protection against cyanide poisoning regardless of particulate filtration limitations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively increases survival rates and protects against cyanide exposure by rapidly neutralizing hydrogen cyanide, blocking free radical damage, and promoting mucous excretion, offering both acute and chronic protection in environments with hazardous cyanide levels.
Implementation Method 1
Hydroxocobalamin binds to hydrogen cyanide to form cyanocobalamin
Implementation Method 2
block free radical chain reactions
Data Source
AI summary
The present invention discloses a composition for upper respiratory tract administration comprising a cyanide antidote and a metal chelator, and the composition is used for cure or protection of fire injury. When carried by a proper carrier, the composition is administrated to a subject in need via forms including a spray, an inhaler, or drops so as to prevent or cure injuries caused by hazardous substances in a fireground.